| # | Drug | Count |
|---|---|---|
| 0 | ERGOCALCIFEROL | 20 |
| 1 | ADALIMUMAB | 13 |
| 2 | ACETAMINOPHEN | 12 |
| 3 | LISINOPRIL | 12 |
| 4 | DALFAMPRIDINE | 11 |
| 5 | PREDNISONE | 11 |
| 6 | CARVEDILOL | 10 |
| 7 | METHOTREXATE SODIUM | 10 |
| 8 | ASPIRIN | 9 |
| 9 | ASPIRIN 325 MG | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BUPRENORPHINE AND NALOXONE | 1 | 0.0008 |
| 1 | ZIPRASIDONE HCL | 2 | 0.0008 |
| 2 | ERGOCALCIFEROL | 20 | 0.0007 |
| 3 | HYDROXYZINE PAMOATE | 2 | 0.0005 |
| 4 | CLINDAMYCIN PHOSPHATE | 3 | 0.0005 |
| 5 | PHENAZOPYRIDINE | 2 | 0.0005 |
| 6 | ACETAMINOPHEN AND CODEINE PHOSPHATE | 1 | 0.0005 |
| 7 | GLUCAGON | 2 | 0.0005 |
| 8 | ZANUBRUTINIB | 2 | 0.0004 |
| 9 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 2 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 29 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 21 |
| 3 | Provitamin D2 Compound [EPC] | 20 |
| 4 | Vitamin C [EPC] | 17 |
| 5 | beta-Adrenergic Blocker [EPC] | 15 |
| 6 | Vitamin B12 [EPC] | 14 |
| 7 | Vitamin D [EPC] | 14 |
| 8 | Kinase Inhibitor [EPC] | 12 |
| 9 | Potassium Channel Blocker [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 1 | Provitamin D2 Compound [EPC] | 20 | 0.0007 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 4 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 5 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |
| 6 | Calcitonin [EPC] | 1 | 0.0003 |
| 7 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 8 | Human alpha-1 Proteinase Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Progestin Antagonist [EPC] | 1 | 0.0002 |